Guardion Health Sciences Inc
NASDAQ:GHSI
Guardion Health Sciences Inc
Cash & Cash Equivalents
Guardion Health Sciences Inc
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guardion Health Sciences Inc
NASDAQ:GHSI
|
Cash & Cash Equivalents
$6.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
Estee Lauder Companies Inc
NYSE:EL
|
Cash & Cash Equivalents
$3.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
B
|
Bellring Brands Inc
NYSE:BRBR
|
Cash & Cash Equivalents
$85m
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Coty Inc
NYSE:COTY
|
Cash & Cash Equivalents
$450m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-9%
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Cash & Cash Equivalents
$21m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-7%
|
|
elf Beauty Inc
NYSE:ELF
|
Cash & Cash Equivalents
$72.7m
|
CAGR 3-Years
27%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
See Also
What is Guardion Health Sciences Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
6.4m
USD
Based on the financial report for Dec 31, 2023, Guardion Health Sciences Inc's Cash & Cash Equivalents amounts to 6.4m USD.
What is Guardion Health Sciences Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
57%
Over the last year, the Cash & Cash Equivalents growth was -60%. The average annual Cash & Cash Equivalents growth rates for Guardion Health Sciences Inc have been -9% over the past three years , 57% over the past five years .